ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Lupartumab Biosimilar - Anti-LYPD3 Antibody - BSA and Azide free (A338828)

Human monoclonal antibody to LYPD3. Research grade Lupartumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 7-10 business days.
Name
Lupartumab Biosimilar - Anti-LYPD3 Antibody - BSA and Azide free
Description
Human monoclonal antibody to LYPD3. Research grade Lupartumab biosimilar.
Applications
ELISA, Flow Cytometry, Functional Studies, in vivo Research
Reactivity
Human
Host
Human
Clonality
Monoclonal
Isotype
IgG1
Conjugate

Unconjugated

Purity
The purity of this Biosimilar is >95%, as determined by SDS-PAGE.
Product Form
Liquid
Formulation
Supplied in 0.01M Phosphate Buffered Saline, pH 7.4.
Storage
Shipped at 4°C. Upon delivery store at 4°C for short-term use (1-2 weeks) or aliquot and store at -20°C for long-term use (up to 12 months).
Synonyms
C4.4A, GPI-anchored metastasis-associated protein C4.4A homolog, Ly6/PLAUR domain-containing protein 3, Matrigel-induced gene C4 protein, MIG-C4
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Lupartumab Biosimilar - Anti-LYPD3 Antibody - BSA and Azide free (A338828)? Please let us know so that we can list the citation on this page.

Alternative products to Lupartumab Biosimilar - Anti-LYPD3 Antibody - BSA and Azide free (A338828)

Proteins predicted to interact with LYPD3

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
98.4% Relevancy Score
91.4% Relevancy Score
75.6% Relevancy Score
70.4% Relevancy Score
55.9% Relevancy Score
55.5% Relevancy Score
53.6% Relevancy Score
52.5% Relevancy Score
52.2% Relevancy Score